GBIO Generation Bio Corp: Net earnings per share growth forecast for next year
Cost reductions driven by the cell-free synthesis of the ceDNA platform optimize the cash flows of Generation Bio Co. (GBIO). The consensus EPS growth forecast for next year confirms this potential, with 84.50 serving as the final level marker. Operational resilience is supported by a network of external laboratories, while high entry costs and patent protection for synthetic carriers create significant barriers for competitors.
Comprehensive metric breakdowns and analytics for Generation Bio (GBIO)
- share price and consensus valuation forecast:
- company stock capitalization data:
- company book value details:
- issuer credit burden and liquidity indicators:
- net income and valuation ratios data:
GBIO - Net Income|Expected Profit Generation Bio Co.|GBIO - Market Cap to Earnings|Projected Price to Earnings Generation Bio Co|GBIO - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Generation Bio|GBIO - Operating profit before depreciation charges|Net earnings per share (EPS TTM) Generation Bio|GBIO - Earnings per share for the last twelve months|Quarterly EPS earnings growth generationbio.com|GBIO - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Generation Bio Co.
Initial company analysis:GBIO, Generation Bio Co.
This indicator reflects the consensus growth forecast for earnings for the coming year, aggregating current analyst calculations to assess fundamental value. The metric's dynamics react instantaneously to operational reports, allowing the market to filter out noise through the forward EPS dynamics model of Generation Bio Co. (GBIO). For Generation Bio Co. (GBIO), such expectations depend directly on the development efficiency of non-viral platforms in Massachusetts and the optimization of costs for outsourced DNA synthesis.
Competitors of Generation Bio Co.
TEM (Tempus AI, Inc) - Earnings growth forecast for next year|Qiagen Corp (QGEN) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Ionis Pharmaceuticals (IONS)|RGEN - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Avidity Biosciences, Inc. RNA|CRSP: Projected earnings per share growth rate for next year|WGS: Expected earnings per share growth for next year|Expected earnings per share trend next year RARE (Ultragenyx Corp)|BEAM: Earnings growth forecast for next year|SRPT (sarepta.com) - Net earnings per share growth forecast for next year|TWST (Twist Bioscience, Inc.) - Earnings growth forecast for next year|10x Genomics Inc (TXG) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Intellia (NTLA)|STOK - Expected net earnings per share growth next year|BioLife Solutions, Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year WVE|Maze Therapeutics - Earnings growth forecast for next year|Sionna Therapeutics, Inc. (SION) - Expected earnings per share growth for next year|Prime Medicine Corp (PRME) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Taysha Corp (TSHA)|Expected earnings per share growth for next year QURE|meiragtx.com (MGTX) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year RGNX|Solid Biosciences Inc (SLDB) - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year OCGN (Ocugen Corp)|PacBio Corp - Net earnings per share growth forecast for next year|Benitec Biopharma Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year designtx.com DSGN|Rocket Pharmaceuticals, Inc. (RCKT) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year 4DMT (FDMT)|LXEO (Lexeo Therapeutics Inc.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year KRRO (Korro Bio, Inc)|Net earnings per share growth forecast for next year Editas Medicine, Inc. (EDIT)|silence-therapeutics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PRQR (ProQR Therapeutics)|Earnings growth forecast for next year Codexis Inc CDXS|Sangamo - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Nautilus Biotechnology (NAUT)|MGX: Earnings growth forecast for next year|Expected net earnings per share growth next year Precision BioSciences Inc. (DTIL)|Net earnings per share growth forecast for next year Boundless Bio|Projected earnings per share growth rate for next year XCUR (Exicure Corp)|Earnings growth forecast for next year IMNN|PHIO - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Mustang Bio MBIO|Expected earnings per share trend next year RNAZ|Bionano - Earnings growth forecast for next year|APDN - Earnings growth forecast for next year|BLUE (Bluebird Bio) - Expected earnings per share growth for next year|IPA: Projected earnings per share increase next year|OMGA (Omega Therapeutics) - Earnings growth forecast for next year|singulargenomics.com (OMIC) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Regulus Therapeutics Inc. (RGLS)|SYRS - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Codex DNA TBIO|TCON: Projected earnings per share growth rate for next year|UBX: Expected earnings per share growth for next year
